{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:56:56Z","timestamp":1791464216800,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"DOI":"10.1007\/s00787-026-03212-2","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:15:44Z","timestamp":1791461744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hallucinations associated with bilastine in a teenager: case report and disproportionality analysis in VigiBase\u00ae"],"prefix":"10.1007","author":[{"given":"Elliot","family":"Ewig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouha","family":"Ben Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Viard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Rocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre O.","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"3212_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1939-4551-1-9-145","volume":"1","author":"FER Simons","year":"2008","unstructured":"Simons FER, Simons KJ (2008) H1 antihistamines: current status and future directions. World Allergy Organ J 1:145\u2013155. https:\/\/doi.org\/10.1186\/1939-4551-1-9-145","journal-title":"World Allergy Organ J"},{"key":"3212_CR2","doi-asserted-by":"publisher","unstructured":"Croitoru D, Brooks SG, Piguet V, MacGillivray L (2021) Cetirizine-induced psychosis in a young adult with erythema multiforme. BMJ Case Rep CP 14:e241393. https:\/\/doi.org\/10.1136\/bcr-2020-241393","DOI":"10.1136\/bcr-2020-241393"},{"key":"3212_CR3","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - CETIRIZINE ALMUS 10\u00a0mg, comprim\u00e9 pellicul\u00e9 s\u00e9cable - Base de donn\u00e9es publique des m\u00e9dicaments. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=62005883&typedoc=R. Accessed 14 Sep 2026"},{"key":"3212_CR4","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - LEVOCETIRIZINE ARROW 5\u00a0mg, comprim\u00e9 pellicul\u00e9 - Base de donn\u00e9es publique des m\u00e9dicaments. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=68779202&typedoc=R. Accessed 14 Sep 2026"},{"key":"3212_CR5","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - DESLORATADINE ALMUS 5\u00a0mg, comprim\u00e9 pellicul\u00e9 - Base de donn\u00e9es publique des m\u00e9dicaments. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=60805549&typedoc=R#RcpEffetsIndesirables. Accessed 14 Sep 2026"},{"key":"3212_CR6","doi-asserted-by":"publisher","unstructured":"J\u00e1uregui I, Garc\u00eda-Lirio E, Soriano AM, et al (2012) An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria. Expert Rev Clin Immunol 8:33\u201341. https:\/\/doi.org\/10.1586\/eci.11.87","DOI":"10.1586\/eci.11.87"},{"key":"3212_CR7","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Gea C, Mart\u00ednez J, Ballester MR, et al (2014) Psychomotor and subjective effects of bilastine, hydroxyzine, and cetirizine, in combination with alcohol: a randomized, double-blind, crossover, and positive-controlled and placebo-controlled Phase I clinical trials. Hum Psychopharmacol Clin Exp 29:120\u2013132. https:\/\/doi.org\/10.1002\/hup.2378","DOI":"10.1002\/hup.2378"},{"key":"3212_CR8","doi-asserted-by":"publisher","unstructured":"Naranjo CA, Busto U, Sellers EM, et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981 Aug;30(2):239\u2009\u2212\u200945. https:\/\/doi.org\/10.1038\/clpt.1981.154","DOI":"10.1038\/clpt.1981.154"},{"key":"3212_CR9","unstructured":"MedDRA Hierarchy | MedDRA. https:\/\/www.meddra.org\/how-to-use\/basics\/hierarchy. Accessed 14 Sep 2026"},{"key":"3212_CR10","doi-asserted-by":"publisher","unstructured":"Nor\u00e9n GN, Hopstadius J, Bate A (2013) Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res 22:57\u201369. https:\/\/doi.org\/10.1177\/0962280211403604","DOI":"10.1177\/0962280211403604"},{"key":"3212_CR11","doi-asserted-by":"publisher","unstructured":"Faillie J-L (2019) Case\u2013non-case studies: Principle, methods, bias and interpretation. Therapies 74:225\u2013232. https:\/\/doi.org\/10.1016\/j.therap.2019.01.006","DOI":"10.1016\/j.therap.2019.01.006"},{"key":"3212_CR12","doi-asserted-by":"publisher","unstructured":"Bergvall T, Nor\u00e9n GN, Lindquist M (2014) vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality Issues. Drug Saf 37:65\u201377. https:\/\/doi.org\/10.1007\/s40264-013-0131-x","DOI":"10.1007\/s40264-013-0131-x"},{"key":"3212_CR13","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez M, Vozmediano V, Garc\u00eda-Bea A (2020) Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria. European Journal of Pediatrics Volume 179, pages 801\u2013805 (2020) https:\/\/doi.org\/10.1007\/s00431-019-03559-6","DOI":"10.1007\/s00431-019-03559-6"},{"key":"3212_CR14","doi-asserted-by":"publisher","unstructured":"Vozmediano V, Sologuren A, Lukas JC, et al (2017) Model Informed Pediatric Development Applied to Bilastine: Ontogenic PK Model Development, Dose Selection for First Time in Children and PK Study Design. Pharm Res 34:2720\u20132734. https:\/\/doi.org\/10.1007\/s11095-017-2248-6","DOI":"10.1007\/s11095-017-2248-6"},{"key":"3212_CR15","doi-asserted-by":"publisher","unstructured":"Kong W, Dong Y, Yi S, et al (2024) High-risks drug adverse events associated with Cetirizine and Loratadine for the treatment of allergic diseases: A retrospective pharmacovigilance study based on the FDA adverse event reporting system database. Clin Transl Allergy 14:e12392. https:\/\/doi.org\/10.1002\/clt2.12392","DOI":"10.1002\/clt2.12392"},{"key":"3212_CR16","doi-asserted-by":"publisher","unstructured":"Boer J, Ederveen E, Grundmark B (2018) Desloratadine and depression, a drug safety signal based on worldwide spontaneous reporting of side effects. Ups J Med Sci 123:174\u2013178. https:\/\/doi.org\/10.1080\/03009734.2018.1489918","DOI":"10.1080\/03009734.2018.1489918"},{"key":"3212_CR17","doi-asserted-by":"publisher","unstructured":"Alta\u015f U, Meva Alta\u015f Z, \u00d6z F (2023) Evaluation of Neuropsychiatric Effects of Montelukast\u2013Levocetirizine Combination Therapy in Children with Asthma and Allergic Rhinitis. Children (Basel). 2023;10(8):1301. https:\/\/doi.org\/10.3390\/children10081301","DOI":"10.3390\/children10081301"},{"key":"3212_CR18","doi-asserted-by":"publisher","unstructured":"Garden BC, Francois D (2013) Cetirizine-Associated Delusions and Depression in an 18-Year-Old Woman. Clin Neuropharmacol 36:96. https:\/\/doi.org\/10.1097\/WNF.0b013e318290b9b2","DOI":"10.1097\/WNF.0b013e318290b9b2"},{"key":"3212_CR19","doi-asserted-by":"publisher","unstructured":"Renko A, Cortese T, Karagiannis P, Salzman M (2022) Unintentional cetirizine overdose causing anticholinergic syndrome. Am J Emerg Med 52:270.e1-270.e3. https:\/\/doi.org\/10.1016\/j.ajem.2021.08.062","DOI":"10.1016\/j.ajem.2021.08.062"},{"key":"3212_CR20","doi-asserted-by":"publisher","unstructured":"Hill AB (1965) The Environment and Disease: Association or Causation? Proc R Soc Med 58:295\u2013300. https:\/\/doi.org\/10.1177\/003591576505800503","DOI":"10.1177\/003591576505800503"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03212-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-03212-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03212-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:15:47Z","timestamp":1791461747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-026-03212-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":20,"alternative-id":["3212"],"URL":"https:\/\/doi.org\/10.1007\/s00787-026-03212-2","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written consent from the parents and the patient\u2019s approval were obtained for the writing of this article.","order":1,"name":"Ethics","label":"Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}